This is the third and final installment in a series examining the strategic implications of reported merger discussions ...

Chinese app BAT BMS is under fire after "Tirri Trend" videos showed remote e-rickshaw shutdowns, causing safety risks, traffic chaos, and driver losses. Authorities are investigating its security ...

Bristol Myers Squibb (NYSE:BMY) moves into focus as reported AstraZeneca deal talks and a busy pharma earnings season shape ...

Bristol Myers Squibb (NYSE:BMY) draws attention as reported AstraZeneca deal talks and a busy pharma earnings season shape ...

The rumors of reported AstraZeneca–Bristol Myers merger discussions provide an opportunity to examine how multiple emerging capabilities may reshape corporate strategy, mergers and acquisitions, and ...

While both drugmakers face looming patent cliffs, analysts say joining forces could help Bristol Myers Squibb replenish its ...

Discover key differences in NiMH vs lithium ion Prius batteries—weight, energy density, cycle life, MPG, cost, and when an ...

The pound traded at USD1.3455 at midday on Monday, down from USD1.3463 at Friday's London equities close. Against the euro, the pound was lower at EUR1.1675 from EUR1.1681. The euro fell to USD1.1518 ...

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) shares fell 6% to 11,872p on Monday, the steepest decline in the FTSE 100, as analysts ...

AstraZeneca has held talks with US rival Bristol Myers Squibb over a merger which could create a drugs giant worth more than ...

Bristol-Myers Squibb Company hits a 52-week high on Q2 results, EPS guidance raise, and key drugs’ momentum. Read why BMY ...

Investors anxiously waiting for Bristol Myers Squibb’s key Alzheimer’s disease psychosis readout for Cabenfy will have to ...